BSE - Delayed Quote • INR
Medinova Diagnostic Services Limited (MEDINOV.BO)
At close: April 23 at 3:24 PM GMT+5:30
Breakdown
TTM
3/31/2023
3/31/2022
3/31/2021
Total Revenue
104,232.00
99,930.00
132,019.00
127,099.00
Cost of Revenue
15,454.00
16,947.00
42,859.00
49,308.00
Gross Profit
88,778.00
82,983.00
89,160.00
77,791.00
Operating Expense
58,736.00
58,430.00
57,011.00
54,904.00
Operating Income
30,042.00
24,553.00
32,149.00
22,887.00
Net Non Operating Interest Income Expense
-5,908.00
-6,151.00
-5,245.00
-3,394.00
Pretax Income
24,792.00
19,001.00
27,969.00
19,622.00
Tax Provision
3,064.00
2,349.00
4,163.00
575.00
Net Income Common Stockholders
21,728.00
16,652.00
22,682.00
20,221.00
Diluted NI Available to Com Stockholders
21,728.00
16,652.00
22,682.00
20,221.00
Basic EPS
2.18
1.67
2.27
2.03
Diluted EPS
2.18
1.67
2.27
2.03
Basic Average Shares
9,961.72
9,981.64
9,981.64
9,981.64
Diluted Average Shares
9,961.72
9,981.64
9,981.64
9,981.64
Rent Expense Supplemental
--
4,477.00
1,910.00
1,577.00
Total Expenses
74,190.00
75,377.00
99,870.00
104,212.00
Net Income from Continuing & Discontinued Operation
21,728.00
16,652.00
22,682.00
20,221.00
Normalized Income
22,900.64
17,824.59
22,682.00
20,221.00
Interest Income
--
314.00
399.00
1,232.00
Interest Expense
5,750.00
5,993.00
5,094.00
4,131.00
Net Interest Income
-5,908.00
-6,151.00
-5,245.00
-3,394.00
EBIT
30,542.00
24,994.00
33,063.00
23,753.00
EBITDA
31,856.00
28,253.00
38,528.00
30,918.00
Reconciled Cost of Revenue
15,454.00
16,947.00
42,859.00
49,308.00
Reconciled Depreciation
1,314.00
3,259.00
5,465.00
7,165.00
Net Income from Continuing Operation Net Minority Interest
21,728.00
16,652.00
22,682.00
20,221.00
Total Unusual Items Excluding Goodwill
-1,338.00
-1,338.00
--
--
Total Unusual Items
-1,338.00
-1,338.00
--
--
Normalized EBITDA
33,194.00
29,591.00
38,528.00
30,918.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-165.36
-165.41
--
--
3/31/2021 - 11/3/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade